tm logo
Trademark Search
SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

View On IC.GC.CA

SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES
SEARCHED

on 15 Jan 2024

Last Applicant/ Owned by

HYBRID CONCEPTS INTERNATIONAL LLC

2135 BEDELL ROAD, SUITE 9BGRAND ISLAND NY 14072

US

Serial Number

2213117 filed on 06th Jun 2022

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

Trademark usage description

assistance, advisory services and consultancy with regard to business planning; business consulting and management in the field of clinical trials, na Read More

Classification Information

Class [035]
Assistance, advisory services and consultancy with regard to business planning; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting services; business consulting services in the field of potential medical cures including cell and gene therapies; business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; business consulting services, namely, providing assistance in development of business strategies and creative ideation; business management consulting and advisory services; business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; consultancy and advisory services in the field of business strategy; consulting services in the field of medical product approval for commercial purposes; international business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; new business venture development and formation consulting services; promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; providing independent review of clinical trials for business purposes; promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations.

Classification kind code

11

Class [036]
Financial consulting services, namely, advising others regarding intellectual property investments; investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products.

Classification kind code

11

Class [042]
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; providing information about medical and scientific research; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research and development; technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific consulting and research services relating to foods and dietary supplements; scientific research consulting in the field of cosmetics.

Classification kind code

11

Class [044]
Consulting services in the field of health; consulting services to health care providers in the field of treating life-changing or life-threatening diseases.

Classification kind code

11

Mark Details

Serial Number

2213117

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 15th Jan 2024		Search Recorded
Submitted for opposition 20
on 15th Jan 2024		Examiner's First Report
Submitted for opposition 223
on 15th Jan 2024		Total Provisional Refusal
Submitted for opposition 236
on 12th Oct 2023		Partial Withdrawal - Madrid Protocol
Submitted for opposition 256
on 31st Jul 2023		Notification of Possible Opposition Sent
Submitted for opposition 31
on 01st Oct 2022		Formalized
Submitted for opposition 1
on 01st Oct 2022		Created
Submitted for opposition 257
on 29th Sep 2022		Designation Notification - Madrid Protocol
Submitted for opposition 228
on 06th Jun 2022		International Registration
Submitted for opposition 30
on 06th Jun 2022		Filed